Human Growth Hormone Releasing Peptides Bremelanotide Powder PT-141/PT141 10mg/ Vial

Injectable Peptide Powder PT141 with Min 99% Purity for Muscles Gaining
 
 

Quick Detail:

 
product descroption: 
 

PT-141 or Bremelanotide is the generic term for a research peptide being studied for its possible use in helping to improve sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder). PT-141 was developed from the tanning peptide Melanotan 2, which is a synthetically produced variant of a peptide hormone naturally produced in the body that stimulates melanogenesis that is known as alpha-Melanocyte stimulating hormone. MSH, activates certain melanocortin receptors in the process of exerting its effects. Indeed, MSH also exerts potent influence over lipid metabolism, appetite, and sexual libido. Resultantly, PT-141 has been shown in studies to exhibit libido-enhancing effects by activating the melanocortin receptors MC1R and MC4R, but not skin tanning. Melanotan 1 and Melanotan 2 have been researched for their use in protecting against the harmful effects of ultraviolet radiation from sunlight due to their melanogenesis-stimulating properties.

As a lifestyle peptide, the 10mg product is a lot to consume and may offer up to 20 doses when dosing light. The PT-141 peptide reconstituted with bacteriostatic water remains potent in the fridge for months.

PT-141 / Bremelanotide is a synthetic heptapeptide analogue of the naturally occuring α-MSH that is currently being studied for its numerous theoretical therapeutic applications. Alpha-MSH has potent influence over lipid metabolism, appetite, and sexual libido.

PT-141/ Bremelanotide is a metabolite of its predecessor MT-2, has the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH and a molecular weight of 1025.2 Dalton.

In initial testing, MT-2 did induce melanogenesis, but caused sexual arousal and spontaneous erections as unexpected side effects in nine out of the ten original male volunteer test subjects Alpha-MSH activates certain melanocortin receptors in the process of exerting its effects.